-

Feinstein Institutes researchers use novel imaging technology to study how the brain and body communicate

MANHASSET, N.Y.--(BUSINESS WIRE)--Bioelectronic medicine researchers at The Feinstein Institutes for Medical Research have developed a new method for studying neural signals transmitted to the brain through the vagus nerve – the nerve that helps controls functions like heart rate, breathing and immune response. By using calcium imaging technology to monitor neural activity from a cluster of neurons near the base of the skull, scientists hope to discover new clues about how the body communicates with the brain.

In a new paper titled “Calcium imaging and analysis of the jugular-nodose ganglia enables identification of distinct vagal sensory neuron subsets,” published in the Journal of Neural Engineering, investigators focused their attention on sensory neurons of the peripheral nervous system (PNS). They wanted to know how these neurons encode and interpret different stimuli in the form of neural activity.

The researchers used imaging of the intact jugular-nodose ganglion – which contains the sensory neurons of the vagus nerve – to directly record neural activity in mice with genetically-encoded calcium indicators. They then analyzed the signals and used a machine learning algorithm to classify the neuronal responses to different types of chemical stimuli applied to the vagus nerve. They found that specific neuronal responses were closely associated with certain types of stimuli, reflecting an encoding of information within the PNS, before further transmission to the brain.

Led by Eric H. Chang, PhD, and postdoctoral researcher Tomás S. Huerta, PhD, the study is part of a multi-year $1.3 million grant from the National Institutes of Health (NIH) to examine how immune signals are transmitted to the brain through the vagus nerve.

“By directly monitoring populations of neurons as they respond to different types of stimuli on the vagus nerve, we begin to see how a diverse range of sensory information can be detected and encoded by these neurons,” said Dr. Chang, assistant professor in the Institute of Bioelectronic Medicine at the Feinstein Institutes. “The information we learn from decoding these signals will help us understand how the vagus nerve communicates with the brain to control many vital physiological functions including respiration, sickness responses and the regulation of inflammation.”

The vagus nerve is often referred to as the body’s superhighway – it connects the brain with all major organs, and controls functions like heart rate, breathing and gastrointestinal function. When the nerve is stimulated, it can reduce inflammation, which is a trigger for many diseases, and help the body’s immune system.

Inflammation is an important immune response, however if uncontrolled, can lead to serious conditions such as Crohn’s disease, rheumatoid arthritis and other chronic inflammatory disorders. In this new study, Feinstein Institutes’ bioelectronic medicine researchers look at how sensory neurons encode and transmit these important physiological signals in the form of neural activity. This information can be used for future research to develop new bioelectronic medicine devices, like vagus nerve stimulators, and better advance our methods to control the signals between the brain and body.

“Dr. Chang’s research enables us to visualize how the vagus nerve processed information before sending it up to the brain,” said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “This is a fascinating new way to think about how the nervous system receives information about the status of inflammation and infection in the body.”

The Feinstein Institutes for Medical Research is the global scientific home of bioelectronic medicine, which combines molecular medicine, neuroscience and biomedical engineering. At the Feinstein Institutes, medical researchers use modern technology to develop new device-based therapies to treat disease and injury.

Built on years of research in molecular mechanisms of disease and the link between the nervous and immune systems, our researchers discover neural targets that can be activated or inhibited with neuromodulation devices, like vagus nerve implants, to control the body’s immune response and inflammation. If inflammation is successfully controlled, diseases – such as arthritis, pulmonary hypertension, Crohn's disease, inflammatory bowel diseases, diabetes, cancer and autoimmune diseases – can be treated more effectively.

Beyond inflammation, using novel brain-computer interfaces, our researchers developed techniques to bypass injuries of the nervous system so that people living with paralysis can regain sensation and use their limbs. By producing bioelectronic medicine knowledge, disease and injury could one day be treated with our own nerves without costly and potentially harmful pharmaceuticals.

About the Feinstein Institutes

The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

The Feinstein Institutes for Medical Research


Release Versions

Contacts

Julianne Mosher Allen
516-880-4824
jmosherallen@northwell.edu

More News From The Feinstein Institutes for Medical Research

Northwell’s Feinstein Institutes’ Kevin J. Tracey named to TIME100 2026 Health list

NEW HYDE PARK, N.Y.--(BUSINESS WIRE)--In recognition of Kevin J. Tracey, MD’s decades-long pursuit into unraveling the mysteries of the brain’s connection to the body and control of inflammation through technology, TIME has named the president and CEO of the Feinstein Institutes for Medical Research at Northwell Health an “Innovator” on its 2026 TIME100 Health list. The recognition spotlights 100 of the world’s most influential leaders transforming global health. Read Dr. Tracey’s profile here...

Feinstein Institutes’ Dr. Stephanie Fitzpatrick elected Fellow of the Academy of Behavior Medicine Research

MANHASSET, N.Y.--(BUSINESS WIRE)--For her leadership in behavioral medicine and health equity, Stephanie L. Fitzpatrick, PhD, a clinical health psychologist, behavioral medicine researcher and implementation scientist at Northwell Health’s Feinstein Institutes for Medical Research, has been elected a Fellow of the Academy of Behavioral Medicine Research (ABMR), the premier honorary scientific organization in her field. The ABMR fellowship recognizes Dr. Fitzpatrick for her extensive contributio...

Northwell Invests in Mental Health, Opens Center for Psychedelics Research and Treatment

MANHASSET, N.Y.--(BUSINESS WIRE)--To address a pressing scientific and public need focused on the therapeutic potential and potential impairing effects of compounds like Δ9-THC (cannabis), psilocybin (mushrooms), MDMA (ecstasy) and ketamine, Northwell Health’s Feinstein Institutes for Medical Research today announced the official opening of the Center for Psychedelics Research and Treatment (CPRT) at Zucker Hillside Hospital in Glen Oaks. The Center will feature a state-of-the-art clinical lab,...
Back to Newsroom